P89. Utilization of Hounsfield units (HU) at L1 for bone quality assessment in ASD surgery is reliable and correlates with a history of osteoporosis

Abstract

<h3>BACKGROUND CONTEXT</h3> As ASD prevalence increases in our ever-aging population there is a hypothetical concomitant increase in poor bone quality, especially if not recognized and not treated. ASD surgery is expensive and carries a high complication profile. It is important to optimize surgical outcomes and reduce complications especially if modifiable preoperative risk factors can be identified, such as osteoporosis. Additional diagnostic modalities such as a DEXA can add cost, delay diagnosis, and can be an additional insurance hurdle. <h3>PURPOSE</h3> Our goal was to examine the utility of HU measurement on preoperative CTs for bone health assessment. <h3>STUDY DESIGN/SETTING</h3> Retrospective cross-sectional review of a prospective, multicenter ASD cohort. <h3>PATIENT SAMPLE</h3> Surgical ASD patients. <h3>OUTCOME MEASURES</h3> Hounsfield Units, history of osteoporosis, DEXA results. <h3>METHODS</h3> Operative ASD patients (scoliosis >20, SVA>5cm, PT>25, or TK>60) were included if they had a preoperative CT. HU were measured by each participating site from axial views within the cancellous body (x3: top, middle, bottom) at both L1 and future UIV. Reliability of the measurement between the 3 acquisitions was performed using instar-class correlation for absolute agreement. Association between HU and patient demographics was assess using Pearson's correlation. Finally, correlation between DEXA measurement and HU was conducted to evaluate relationship between bone quality and HU values. <h3>RESULTS</h3> There were 694/1493 (46%) patients who had a CT including either L1 or UIV. And 521 patients were identified as having both L1 and UIV measurement. Also, 71.8% were female with a mean age of 63years±12.5, 52.6% were revision with mean levels fused of 10.5±4.5. The intraclass correlation coefficient (ICC) for UIV and L1 were 0.767 (95CI 0.737-0.796]) and 0.802 (95CI [0.774 0.827]), respectively. Previous instrumentation did not affect L1 HU ICC (r=0.798 vs r=0.809) and showed no significant difference in HU value (p=0.232). Comparison of L1 HU between different sites demonstrated no significant difference (p=0.43). Comparison of L1 and UIV did show a significant difference (L1:151±77 vs 160±62 p<0.001) although there was a significant correlation (r=0.631 p<0.001). The mean HU value at L1 was consistent with previously published values (p=0.542). There were 116 (22.5%) patients who had a DEXA and 97 (18.6%) patients reported a history of osteoporosis. Comparison of DEXA and HU between patients with and without history of osteoporosis showed a significant difference in HU (155±76 vs 134±79 p<0.001) and but not in DEXA (p=0.07). A significant but weak association between DEXA and HU measurements (r=0.286 & 0.285 p<0.002). HU did not correlate with baseline demographic parameters such as BMI, CCMI, or frailty but did correlate with age (p<0.009 r=-0.215). Similarly, DEXA did not correlate with baseline demographic parameters except for BMI (p<0.002,r=0.298). <h3>CONCLUSIONS</h3> In this large cohort of surgical ASD patients, bone quality assessment was available for 18% of patients via DEXA or 46% via HU on CT. HU measured from an axial image of L1 and UIV appears to be a reliable assessment of bone quality. Previous instrumentation did not alter the measurements. There was a significant but weak correlation when comparing HU to DEXA. Patients with a reported history of osteoporosis had lower HU. <h3>FDA DEVICE/DRUG STATUS</h3> This abstract does not discuss or include any applicable devices or drugs.